Boehringer Ingelheim and CDR-Life have announced a worldwide licencing agreement for the development of CDR111, an antibody-based molecule targeting autoimmune conditions. CDR111 …
The path to approval for uniQure’s gene therapy candidate for Huntington’s disease is in doubt as the US Food and …
George Tidmarsh has resigned from the US Food and Drug Administration (FDA), becoming the latest in a long line of …
The top 20 global biopharmaceutical companies experienced mixed performances in their individual market capitalisations in the third quarter (Q3) of …
While surveillance data from 2024 shows an encouraging reduction in HIV transmissions1, more needs to be done to meet the …
George Tidmarsh has resigned from the US Food and Drug Administration (FDA), becoming the latest in a long line of …
The top 20 global biopharmaceutical companies experienced mixed performances in their individual market capitalisations in the third quarter (Q3) of …
While surveillance data from 2024 shows an encouraging reduction in HIV transmissions1, more needs to be done to meet the …
Kimberly-Clark has agreed to acquire Johnson & Johnson (J&J) consumer health spinout Kenvue for $48.7bn. One of America’s largest consumer health …
The US Food and Drug Administration (FDA) has approved UCB’s Kygevvi (doxecitine and doxribtimine) to treat genetic mitochondrial disease, thymidine …
Eli Lilly and Company has outlined plans to develop a $3bn manufacturing facility in Katwijk, situated in the Leiden Bio …
According to Cancer Research UK, prostate cancer is the most common cancer among men in the UK, representing 28% of …
Alvotech’s inflammation-targeting biosimilar AVT05 has been rejected by the U.S. Food and Drug Administration (FDA) because of issues with the …
Pfizer has followed through on its threats, filing a lawsuit against both Metsera and Novo Nordisk during a M&A bidding …
18 October 2025 marked the presentation of the highly anticipated OptiTROP-Breast02 trial at the 2025 European Society for Medical Oncology …
